Crossmark

A tumor treatment strategy based on biodegradable BSA@ZIF-8 for simultaneously ablating tumors and inhibiting infection

Crossref DOI link: https://doi.org/10.1039/C8NH00113H

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Wu, Qiong

Li, Mei

Tan, Longfei

Yu, Jie

Chen, Zengzhen

Su, Liuhui

Ren, Xiangling

Fu, Changhui

Ren, Jun

Li, Laifeng

Cao, Feng

Liang, Ping https://orcid.org/0000-0002-7640-2351
Zhang, Yu

Meng, Xianwei https://orcid.org/0000-0002-0350-4760
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (61671435, 81671845, 81630053)

Natural Science Foundation of Beijing Municipality (4161003)
License Information

Accepted Manuscript valid from 2019-07-11
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Ping Liang (ORCID)

: Xianwei Meng (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 19 May 2018; Accepted 3 July 2018; Advance Article published 11 July 2018; Version of Record published 22 October 2018